From months to minutes
Our multi-laser technology can detect and distinguish between different causes of dementia, allowing clinicians to reduce diagnosis time from many months to just a few minutes.
<5
minute
Detection time of different dementia causes
93%
accuracy
For identifying Alzheimer’s at pre-clinical trials
Faster and more precise
Current dementia testing methods are costly, inaccessible to many and mostly used for late-stage diagnosis. Our technology generates ‘optical fingerprints’ from blood samples that are unique to different types of dementia and enable accurate identification of dementia, earlier and faster.
Faster and more precise
Current dementia testing methods are costly, inaccessible to many and mostly used for late-stage diagnosis. Our technology generates ‘optical fingerprints’ from blood samples that are unique to different types of dementia and enable accurate identification of dementia, earlier and faster.
55 million people are living with dementia
10 million people are diagnosed with dementia annually. The best care comes through identifying the specific type of dementia, as early as possible.
A dementia diagnosis can take up to 2 years
Neurologist assessments, memory clinics, cognitive testing and follow-ups can take more than two years, and the average lag from referral to diagnosis continues to grow.
The cost of delayed diagnosis
Delayed diagnosis can lead to more complex symptoms, higher care demands, and an increased cost to support. Dementia can also mask other illnesses that can be treated sooner with earlier diagnosis.
Proven, simple, and scalable
Refined through NHS trials, our MX-Raman® technology is protected with patents pending in the USA, UK and EU and set to transform how healthcare systems diagnose and treat dementia at scale.
Dementia is a terrible disease that I have experienced from close quarters and I am sure everyone would have had some experience with family or friends. Now that treatments and cures are emerging it is imperative to have better methods for quick and early diagnosis. Our Novel MX- Raman technology addresses this crucial gap and I truly believe can transform dementia detection.
Professor Sumeet Mahajan
Co-founder, CEO and CTO
Faster and more precise
Current dementia testing methods are costly, inaccessible to many and mostly used for late-stage diagnosis. Our technology generates ‘optical fingerprints’ from blood samples that are unique to different types of dementia and enable accurate identification of dementia, earlier and faster.